A000020 Stock Overview
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Dongwha Pharm.Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,660.00 |
| 52 Week High | ₩11,120.00 |
| 52 Week Low | ₩8,340.00 |
| Beta | 1.11 |
| 1 Month Change | -3.13% |
| 3 Month Change | -10.26% |
| 1 Year Change | 1.88% |
| 3 Year Change | -40.48% |
| 5 Year Change | -7.77% |
| Change since IPO | 229.43% |
Recent News & Updates
Recent updates
Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations
Mar 26
Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?
Apr 28These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%
Feb 22Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?
Feb 07Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?
Jan 23Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?
Jan 08
Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days
Dec 24We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability
Dec 19Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?
Nov 19Shareholder Returns
| A000020 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.5% | 1.2% | 1.8% |
| 1Y | 1.9% | 10.0% | 9.5% |
Return vs Industry: A000020 underperformed the KR Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: A000020 underperformed the KR Market which returned 9.5% over the past year.
Price Volatility
| A000020 volatility | |
|---|---|
| A000020 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A000020 has not had significant price volatility in the past 3 months.
Volatility Over Time: A000020's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1897 | 810 | Doh Yoon | www.dong-wha.co.kr |
Dongwha Pharm Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics.
Dongwha Pharm.Co.,Ltd Fundamentals Summary
| A000020 fundamental statistics | |
|---|---|
| Market cap | ₩243.09b |
| Earnings (TTM) | ₩27.44b |
| Revenue (TTM) | ₩361.11b |
8.7x
P/E Ratio0.7x
P/S RatioIs A000020 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000020 income statement (TTM) | |
|---|---|
| Revenue | ₩361.11b |
| Cost of Revenue | ₩170.69b |
| Gross Profit | ₩190.42b |
| Other Expenses | ₩162.98b |
| Earnings | ₩27.44b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 989.91 |
| Gross Margin | 52.73% |
| Net Profit Margin | 7.60% |
| Debt/Equity Ratio | 7.5% |
How did A000020 perform over the long term?
See historical performance and comparison